CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 29.35 Min. order: 1 piece ★★★★★ 5.0 (114 reviews) Sold : Login>>
Cagrilintide + Semaglutide – Peptide Research Blend – PRG US$ 28.45 Min. order: 1 piece ★★★★★ 4.7 (81 reviews) Sold : Login>>
BPC-157: Miracle Healing Peptide or Hidden Danger? US$ 28.90 Min. order: 1 piece ★★★★★ 4.1 (202 reviews) Sold : Login>>
Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta-Analysis US$ 20.45 Min. order: 1 piece ★★★★★ 4.8 (137 reviews) Sold : Login>>
Cagrilintide & Semaglutide in Overweight Adults (REDEFINE-1) | NEJM US$ 21.87 Min. order: 1 piece ★★★★★ 4.2 (106 reviews) Sold : Login>>
New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 25.06 Min. order: 1 piece ★★★★★ 4.6 (169 reviews) Sold : Login>>